One thing I find interesting, and that potential may minimize or eliminate the benefits of later life reductions of GH/IGF1 as a life extension strategy, is that the lifespan benefits of low growth hormone / IGF1 levels are significantly reduced in these long-lived strains of mice if they are given a few weeks of GH injections to normalize their GH/IGF1 levels during that short period.
In this study, done by Richard Miller’s team, they found that only a few weeks of GH injections reversed many aspects of the longevity phenotype. I’m not sure if there have been any studies yet on low-GH / IGF1 levels implemented later in life.
The exceptional longevity of Ames dwarf (DF) mice can be abrogated by a brief course of growth hormone (GH) injections started at 2 weeks of age. This transient GH exposure also prevents the increase in cellular stress resistance and decline in hypothalamic inflammation characteristic of DF mice. Here, we show that transient early-life GH treatment leads to permanent alteration of pertinent changes in adipocytes, fat-associated macrophages, liver, muscle, and brain that are seen in DF mice.
…
Thus, many of the traits seen in long-lived mutant mice, pertinent to age-related changes in inflammation, neurogenesis, and metabolic control, are permanently set by early-life GH levels.
source: Transient early life growth hormone exposure permanently alters brain, muscle, liver, macrophage, and adipocyte status in long-lived Ames dwarf mice - PubMed
In other words, these Ames dwarf mice in this study had low GH/IGF1 levels their entire life, except for this brief period of a few weeks when the injected higher levels of GH/IGF1, and the result was that many of the benefits of low GH/IGF1 were eliminated. The question that then comes up is if we as humans have mostly higher GH/IGF1 until age (pick a number, 30, 40, 50 years), and then we lower it, will we see any benefits that are seen in the Ames dwarf mice from lifelong low GH/IGF1.
So - there is the question in my mind as to whether later life GH/IGF1 restriction will accomplish significant longevity benefits. But I’ve not searched all the literature on this issue. Perhaps someone else has some knowledge in this area.
At the same time, it doesn’t seem like there is much risk with lower IGF1 or GH, given the normal lifespans of Laron syndrome people.